SE8501392D0 - Cyclosporine, ihre herstellung und verwendung - Google Patents

Cyclosporine, ihre herstellung und verwendung

Info

Publication number
SE8501392D0
SE8501392D0 SE8501392A SE8501392A SE8501392D0 SE 8501392 D0 SE8501392 D0 SE 8501392D0 SE 8501392 A SE8501392 A SE 8501392A SE 8501392 A SE8501392 A SE 8501392A SE 8501392 D0 SE8501392 D0 SE 8501392D0
Authority
SE
Sweden
Prior art keywords
mebmt
nva
val
alpha
cyclosporine
Prior art date
Application number
SE8501392A
Other languages
English (en)
Other versions
SE8501392L (sv
SE461334B (sv
Inventor
R Wenger
R P Traber
H Kobel
H Hofmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8501392D0 publication Critical patent/SE8501392D0/sv
Publication of SE8501392L publication Critical patent/SE8501392L/sv
Publication of SE461334B publication Critical patent/SE461334B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8501392A 1984-03-23 1985-03-21 Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat SE461334B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (3)

Publication Number Publication Date
SE8501392D0 true SE8501392D0 (sv) 1985-03-21
SE8501392L SE8501392L (sv) 1985-09-24
SE461334B SE461334B (sv) 1990-02-05

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501392A SE461334B (sv) 1984-03-23 1985-03-21 Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat

Country Status (24)

Country Link
US (1) US4639434A (sv)
JP (1) JPH08838B2 (sv)
AT (1) AT388737B (sv)
BE (1) BE901980A (sv)
CA (1) CA1247546A (sv)
CH (1) CH667274A5 (sv)
CS (1) CS249542B2 (sv)
DE (1) DE3509809A1 (sv)
DK (1) DK128285A (sv)
ES (1) ES8702926A1 (sv)
FI (1) FI851120L (sv)
FR (1) FR2561651B1 (sv)
GB (1) GB2155936B (sv)
GR (1) GR850716B (sv)
HU (1) HU200786B (sv)
IL (1) IL74681A (sv)
IT (1) IT1199962B (sv)
LU (1) LU85819A1 (sv)
NL (1) NL8500828A (sv)
NO (1) NO851160L (sv)
NZ (1) NZ211526A (sv)
PH (2) PH23357A (sv)
PT (1) PT80149B (sv)
SE (1) SE461334B (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92501T1 (de) 1984-10-04 1993-08-15 Sandoz Ag Monoklonale antikoerper gegen zyklosporine.
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
DE3888357T2 (de) * 1987-06-22 1994-09-15 Merck & Co Inc Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
EP0391909B1 (en) * 1987-09-03 1994-08-17 The University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (sv) * 1988-05-13 1991-12-31 Sandoz Ag
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
CZ280909B6 (cs) * 1990-11-02 1996-05-15 Novartis Ag Nové cyklosporiny
DE69133095T2 (de) 1990-11-20 2003-03-27 Dade Behring Marburg Gmbh Cyclosporin-Immunoassay
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
EP0991660B8 (en) 1997-10-08 2006-04-05 Isotechnika,Inc. DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US5990274A (en) * 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
PT1436321E (pt) 2001-10-19 2006-10-31 Isotechnika Inc Sintese de analogos de ciclosporina
KR100978836B1 (ko) * 2001-10-19 2010-08-30 이소테크니카 인코포레이티드 신규한 시클로스포린 유사체 미세유화액 예비농축물
AU2004222306A1 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
WO2006039163A2 (en) * 2004-09-29 2006-04-13 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
US7511013B2 (en) * 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
EP1812037A4 (en) * 2004-10-06 2009-11-11 Amr Technology Inc ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7576057B2 (en) 2006-11-20 2009-08-18 Scynexis, Inc. Cyclic peptides
JP6144627B2 (ja) 2010-12-15 2017-06-07 コントラヴィア ファーマシューティカルズ、インク． アミノ酸１および３で修飾されたシクロスポリン類似体分子
CA2852056C (en) 2011-03-11 2021-08-10 Beth Israel Deaconess Medical Center, Inc. Anti-cd40 antibodies and uses thereof
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
PT3307322T (pt) 2015-09-04 2021-04-23 Primatope Therapeutics Inc Anticorpos anti-cp40 humanizados e as suas utilizações referência cruzada relativa às aplicações associadas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine
US4384996A (en) * 1981-01-09 1983-05-24 Sandoz Ltd. Novel cyclosporins

Also Published As

Publication number Publication date
DE3509809A1 (de) 1986-01-09
IT1199962B (it) 1989-01-05
PH23357A (en) 1989-07-14
IT8547852A1 (it) 1986-09-22
GB8507270D0 (en) 1985-04-24
NO851160L (no) 1985-09-24
JPH08838B2 (ja) 1996-01-10
FR2561651A1 (fr) 1985-09-27
AT388737B (de) 1989-08-25
GB2155936A (en) 1985-10-02
NZ211526A (en) 1988-08-30
IL74681A0 (en) 1985-06-30
US4639434A (en) 1987-01-27
ES8702926A1 (es) 1987-01-16
DK128285A (da) 1985-09-24
NL8500828A (nl) 1985-10-16
PH21868A (en) 1988-03-25
PT80149B (en) 1987-03-23
ES541465A0 (es) 1987-01-16
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
HUT38370A (en) 1986-05-28
SE8501392L (sv) 1985-09-24
BE901980A (fr) 1985-09-23
FR2561651B1 (fr) 1990-03-09
IL74681A (en) 1989-09-10
GB2155936B (en) 1987-09-16
CS249542B2 (en) 1987-03-12
PT80149A (en) 1985-04-01
LU85819A1 (fr) 1985-12-12
DK128285D0 (da) 1985-03-21
HU200786B (en) 1990-08-28
JPS60215700A (ja) 1985-10-29
GR850716B (sv) 1985-07-19
CH667274A5 (de) 1988-09-30
FI851120L (fi) 1985-09-24
SE461334B (sv) 1990-02-05
FI851120A0 (fi) 1985-03-20
IT8547852A0 (it) 1985-03-22

Similar Documents

Publication Publication Date Title
SE8501392D0 (sv) Cyclosporine, ihre herstellung und verwendung
DK109486A (da) Cyclosporiner
IT1157923B (it) Procedimento per minimizzare l'emissione di impurita' da impianti di combustione
DE3378052D1 (en) Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
DE69816291D1 (de) Dicker mit laser segmentierter keramischer hitzeschild für den anstreifring von turbinen
DK0414632T3 (da) Cyclosporinderivater
SE8500107L (sv) Nya 8-alfa-acylaminoergoline
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
DE3561153D1 (de) Benzoylurea derivatives
CA2184871A1 (en) Anticonvulsive 1-ar(alk)ylimidazolin-2-ones, and process for making
DK0538314T3 (da) Indano-pyrrolidincarbamater
FI874586A (fi) Syntes av peptid-aminoalkylaminer och peptidhydrazider medelst fastfasfoerfarande.
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
AU541234B2 (en) Substituted-6-halogenic-t-butyl-1,2,4-triazin-5-ones
ATE97130T1 (de) 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln.
PH14733A (en) Diuretic compositions
DK401287D0 (da) Fremgangsmaade til fremstilling af opstisk aktive forbindelser
SU963090A1 (ru) Запоминающее устройство
IL82963A0 (en) 3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3-heteroarylureas and thioureas,their preparation and their use as herbicides
ATE79882T1 (de) Antibakterielle verbindungen.
ES8606868A1 (es) Procedimiento para la obtencion de derivados de la 1,4-dihi-dro-piridina
TH14317EX (th) 7-(ซับสทิทิวเทด)-9-[(ซับสทิทิวเทด ไกลซิล)แอมิโด]-6-ดีเมธิล-6-ดีออกซิเททระไซคลีน
IT8619932A0 (it) Procedimento per la fabbricazione di guarnizioni di tenuta anulari ad ampia latitudine d'impiego e guarnizioni di tenuta anulari ottenute con il detto procedimento.
RU95114125A (ru) Ингибитор пролиферации стволовых кроветворных клеток

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8501392-8

Effective date: 19911009

Format of ref document f/p: F